New Medical & Scientific Advisory Board Member
The addition of Dr. Kim to our Medical and Scientific Advisory Board “will help drive our product development strategy of leveraging science-based intellectual property to solve mega-trend health problems," said Gregory L. Probert, Chairman and CEO of Synergy/NSP. "We believe that Dr. Kim's vast research in the field of metabolic dysfunction will allow him to be a terrific asset in terms of our product development. We're excited about this partnership and look forward to the expertise that he brings to our company."
Dr. Matt Tripp, Synergy/NSP's Chief Scientific Officer, added, “Dr. Kim's extensive research background and knowledge will be of great value in helping guide us to new discoveries and innovations."